Dr. Shakir Ullah

Assistant Professor
Khyber Medical University, Peshawar, Pakistan


Highest Degree
PostDoc. in Neurosciences from Shantou University Medical College, China

Share this Profile

Area of Interest:

Neuroscience
Neuropharmacology
Pharmacogenomics and Pharmacogenetics
Neurogenetics and Epigenetic
Alzheimer’s Disease

Selected Publications

  1. Ullah, S., N. Ali, S. Ahmad, S.W.A. Sha, S. Ali and F. Almarshad, 2022. The likelihood approach for potential role of GABRG2 (C588T, C315T) gene polymorphisms on the poor response to carbamazepine therapy in Pakhtun population of Pakistan. Medicines, Vol. 9. 10.1097/md.0000000000030948.
    CrossRef  |  Direct Link  |  

  2. Rehman, M.U., S. Ghazanfar, R. Ul Haq, S. Ullah and S. Khan et al., 2022. Probiotics (Bacillus clausii and Lactobacillus fermentum Nmcc-14) ameliorate stress behavior in mice by increasing monoamine levels and mRNA expression of dopamine receptors (D1 and D2) and synaptophysin. Front. Pharmacol., Vol.13. 10.3389/fphar.2022.915595.
    CrossRef  |  Direct Link  |  

  3. Zakria, M., N. Ahmad, L.T. Al Kury, A. Alattar and Z. Uddin et al., 2021. Melatonin rescues the mice brain against cisplatin-induced neurodegeneration, an insight into antioxidant and anti-inflammatory effects. NeuroToxicology, 87: 1-10.
    CrossRef  |  Direct Link  |  

  4. Ali, S., H. Kumar, S. Ullah, M.A.U. Haq, N.G. Gul and J. Kumar, 2021. Electroencephalography patterns of subacute sclerosing panencephalitis. Cureus, Vol. 13. https://doi.org/10.7759/cureus.15728.
    CrossRef  |  Direct Link  |  

  5. Kamran, M., R. Kousar, S. Ullah, S. Khan and M.F. Umer et al., 2020. Taxonomic distribution of medicinal plants for Alzheimers disease: A cue to novel drugs. Int. J. Alzheimers Dis., 10.1155/2020/7603015.
    CrossRef  |  Direct Link  |  

  6. Farooq, N., N. Ali and S. Ullah, 2019. Evaluation of hematological parameters in the genetic prospective in epileptic patients of Khyber Pakhtunkhwa. Pharmacogenomics Person. Med., 12: 377-385.
    CrossRef  |  Direct Link  |  

  7. Ullah, S., N. Ali, A. Khan, S. Ali, H.R. Nazish and Z. Uddin, 2018. Epilepsy control with carbamazepine monotherapy from a genetic perspective. BMC Pharmacol. Toxicol., Vol. 19. 10.1186/s40360-018-0261-y.
    CrossRef  |  Direct Link  |  

  8. Ullah, S., N. Ali, A. Khan, S. Ali and H.R. Nazish, 2018. The epidemiological characteristics of epilepsy in the province of Khyber Pakhtunkhwa, Pakistan. Front. Neurol., Vol. 9. 10.3389/fneur.2018.00845.
    CrossRef  |  Direct Link  |  

  9. Nazish, H.R., N. Ali and S. Ullah, 2018. The possible effect of SCN1A and SCN2A genetic variants on carbamazepine response among Khyber Pakhtunkhwa epileptic patients, Pakistan. Ther. Clin. Risk Manag., 14: 2305-2313.
    CrossRef  |  Direct Link  |  

  10. Ali, N., R. Begum, M.S. Faisal, A. Khan and M. Nabi et al., 2016. Current statins show calcium channel blocking activity through voltage gated channels. BMC Pharmacol. Toxicol., Vol. 43. 10.1186/s40360-016-0086-5.
    CrossRef  |  Direct Link  |